MARKET

AQST

AQST

Aquestive Therapeutics
NASDAQ
2.770
-0.040
-1.42%
Closed 19:38 06/13 EDT
OPEN
2.830
PREV CLOSE
2.810
HIGH
2.860
LOW
2.745
VOLUME
619.25K
TURNOVER
0
52 WEEK HIGH
6.23
52 WEEK LOW
1.251
MARKET CAP
252.18M
P/E (TTM)
-6.4810
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AQST last week (0603-0607)?
Weekly Report · 4d ago
Aquestive Therapeutics Shares Investor Presentation Update
TipRanks · 06/07 12:58
Aquestive Therapeutics Appoints Cassie Jung as COO
TipRanks · 06/06 21:13
Aquestive Therapeutics Price Target Maintained With a $9.00/Share by HC Wainwright & Co.
Dow Jones · 06/05 11:24
HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $9 Price Target
Benzinga · 06/05 11:17
Aquestive Therapeutics Poised for Growth with Anaphylm™ and Strategic Executive Additions: A Buy Rating Justified
TipRanks · 06/05 10:19
*Aquestive Therapeutics Appoints Cassie Jung Oper Chief >AQST
Dow Jones · 06/03 12:01
AQUESTIVE THERAPEUTICS ANNOUNCES EXECUTIVE APPOINTMENTS AND BUILDS COMMERCIAL CAPABILITIES
Reuters · 06/03 12:00
More
About AQST
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. It is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis. It has also developed a product pipeline focused on treating diseases of the central nervous system (CNS). Its PharmFilm technology is comprised of proprietary polymer compositions that serve as film formers to hold active pharmaceutical ingredients (APIs), and excipients in place. Its product portfolio and pipeline include Anaphylm, AQST-108, and Adrenaverse. Its CNS product candidate include Libervant. The Company’s Licensed commercial products and product candidates and other product includes Suboxone, Exservan, KYNMOBI, Zuplenz, Azstarys, Libervant, and Sympazan. Anaphylm is a non-device based, orally delivered epinephrine product candidate.

Webull offers Aquestive Therapeutics Inc stock information, including NASDAQ: AQST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AQST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AQST stock methods without spending real money on the virtual paper trading platform.